K. O'Shaughnessy

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.

C. Dollery, K. O'Shaughnessy, F. O'Connell, 1993, The American review of respiratory disease.

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

C. Dollery, K. O'Shaughnessy, I. K Taylor, 1991, The Lancet.

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.

K. O'Shaughnessy, R. Fuller, B. Gillies, 1993, The American review of respiratory disease.